SCHEMBL29977131

SCHEMBL29977131

CCCC(=O)c1cc(C)c(-c2cc3cnc(Cl)cc3n(C)c2=O)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 15/20 0.38
SRC P12931 15/20 0.38
CYP11B2 P19099 1/20 0.34
GABRA1 P14867 3/20 0.33
GABRG2 P18507 3/20 0.33
GABRB3 P28472 3/20 0.33
GABRA5 P31644 3/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33
GABRG1 Q8N1C3 1/20 0.33
GABRG3 Q99928 1/20 0.33
GABRQ Q9UN88 1/20 0.33
CCR9 P51686 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24666732 1.00 FGFR1 (0.38) FGFR1SRCCYP11B2GABRA1GABRG2
SCHEMBL24666542 0.92 FGFR1 (0.39) FGFR1SRCCYP11B2CCR9
SCHEMBL24667115 0.90 CCR9 (0.35) FGFR1SRCGABRA1GABRG2GABRB3
SCHEMBL30884991 0.89 FGFR1 (0.36) FGFR1SRC
SCHEMBL30884962 0.89 BTK (0.41) FGFR1SRCCCR9
SCHEMBL24667279 0.88 KRAS (0.34) FGFR1SRCGABRA1GABRG2GABRB3
SCHEMBL29977585 0.88 KRAS (0.34) FGFR1SRCGABRA1GABRG2GABRB3
SCHEMBL29977900 0.88 SRC (0.47) FGFR1SRCGABRA1GABRG2GABRB3
SCHEMBL24667123 0.87 FGFR1 (0.38) FGFR1SRC
SCHEMBL29977554 0.86 SRC (0.38) FGFR1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022236319-A1 NAPHTHYRIDONE COMPOUNDS FOR INHIBITION OF RAF KINASES AND/OR BCR-ABL TYROSINE KINASES ENLIVEN THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed